Delcath Systems

(: DCTHD)

Symbol has changed to a new ticker symbol

(DCTH)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Delcath Systems Inc is a specialty pharmaceutical and medical device company. It is engaged in the development and commercialization of CHEMOSAT/Melphalan/HDS. The company focuses on the treatment of primary and metastatic liver cancers. Its investigational product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website: www.delcath.com
Email: investorrelations@delcath.com
Main Phone: +1 212 489-2100
Address: 1633 Broadway
Address 2: 22nd Floor, Suite C
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: OTCQB
CEO: Jennifer K. Simpson
Employees: 43
NAICS: Medical Laboratories(621511)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A